Skip to main content

Table 2 ATMP-CD133 production and delivery

From: Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)

Parameter Value
BM harvest (ml) 349 ± 57
ATMP-CD133 production
 Cellularity (× 106) 6.57 ± 3.45
 Purity (%) 88.77 (86.30–90.75)
 Vitality (%) 99.90 (99.85–99.95)
ATMP-CD133 delivery
 Number of injections 12 (11–12)
 Procedural duration (min) 252 ± 91
 Mapping and injection time (min) 105 ± 29
 Fluoroscopy time (min) 63 ± 22
  1. Data presented as mean ± standard deviation or median (interquartile range), as appropriate
  2. ATMP advanced therapy medicinal product, BM bone marrow